HBSC.OB ----------- > Organ Preservation - 500 Beiträge pro Seite

[circuit]

Es tut sich wieder etwas.

Nachdem dieser Thread ---- > Thread: HUMAN BIOSYSTEMS (WKN 164580) - Volles Orderbuch!

bereits ins Archiv verschoben war:

Human BioSystems Accelerates Organ Research and Reduces Staff Expenses
Tuesday February 15, 7:00 am ET


PALO ALTO, Calif.--(BUSINESS WIRE)--Feb. 15, 2005--Human BioSystems (OTCBB:HBSC - News), a biomedical research company focused on creating preservation solutions for biological materials, announced that it has taken steps to accelerate its organ preservation research while reducing expenses.
"The Company has endured a long period of financial hardship to this point," said Harry Masuda, the Company`s CEO. "We have recently established a flow of investment capital, mostly from European investors, that should help us significantly toward achieving our scientific and corporate goals."

"In order to maximize our scientific efforts, we decided to allocate additional resources to the organ preservation research by doubling the number of animal organ preservation experiments as compared to the current schedule. This should shorten the timetable for achieving the scientific milestones we have set for ourselves," according to Luis Toledo, the Company`s Chief Medical Officer.

The Company also recently resumed its platelet human infusion tests which should be concluded within the next four to six months .

"At the same time that we add more resources to accelerate the organ preservation effort and resume human infusion tests, we must reduce expenses in other areas," said Masuda. "We made the decision to change our overall compensation structure to reduce our recurring payroll expenses in currently non-critical areas of the company, while providing additional resources toward completing our scientific objectives" said Masuda.

Human BioSystems is headquartered in Palo Alto, California.

[circuit]

Nun bei 0,28 ....und immer noch keine news, welche diesen Anstieg begründen könnten: